← Open Payments lookup

RAMESH ELURI: Open Payments

NPI 1497706097 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$10,448 in 114 payments from 15 companies in 2025. Trend: 2023 $32,187 · 2024 $1,933 · 2025 $10,448

Consulting: $6,325Food & beverage: $2,813Travel & lodging: $1,309
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.21$8,386
Otsuka America Pharmaceutical, Inc.16$477
Janssen Pharmaceuticals, Inc18$398
ABBVIE INC.15$312
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$191
Neurocrine BioSciences, Inc.6$152
Vanda Pharmaceuticals Inc.7$119
Alkermes, Inc.5$110
Lundbeck LLC4$77
Teva Pharmaceuticals USA, Inc.4$62

Products named: COBENFY, VRAYLAR, INVEGA SUSTENNA, ABILIFY ASIMTUFII, CAPLYTA, SPRAVATO, ABILIFY MAINTENA, REXULTI.

Industry payments across PA — which companies pay providers there.